Adolescents With Inflammatory Bowel Disease Have Decreased Rates of Health Maintenance Visits.


Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
01 08 2021
Historique:
pubmed: 4 5 2021
medline: 15 10 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD) commonly presents during adolescence and may affect health care utilization. This study aimed to assess rates of health maintenance examinations (HMEs) in adolescents with IBD with their primary care physicians (PCPs). This is a single center, case-control study of adolescents with IBD who received their IBD care and primary care within the same healthcare system. Adolescents diagnosed with IBD between 13 and 17 years of age were matched 1:1 by age, gender, race/ethnicity, and insurance status to healthy controls. Patient demographics, IBD characteristics, and health outcomes were extracted from the medical record. HME rate was defined as having one HME with a PCP during a 12-month period. This study included 150 IBD-control matched pairs. HME rates were similar at baseline between cases and controls (83% vs 85%, P = 0.53) but approached significance in year 1 post-diagnosis (77% vs 85%, P = 0.056). In year 2 post-diagnosis, IBD patients had less frequent HME (62% vs 74%, P = 0.0486). Disease severity did not affect HME rates. IBD patients from under-represented minority groups had lower rates than matched controls (46.2% vs 91.7%, P = 0.03). Meningococcal and human papilloma vaccination rates were lower in cases versus controls (79% vs 94%, P = 0.0005 and 60% vs 84%, P < 0.0001). Adolescents with IBD have less frequent HME and lower rates of certain vaccinations than their peers. Those from underrepresented minority groups are at particular risk. Given the important issues addressed at HMEs, gastroenterologists should recommend that adolescents with IBD have ongoing PCP engagement to optimize health outcomes.

Identifiants

pubmed: 33938525
doi: 10.1097/MPG.0000000000003155
pii: 00005176-202108000-00022
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-250

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Sauer CG, Kugathasan S. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Med Clin North Am 2010; 94:35–52.
Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146:35–40.
Sainato R, Flores M, Malloy A, et al. Health maintenance deficits in a fully insured population of adolescents with chronic medical conditions. Clin Pediatr (Phila) 2017; 56:512–518.
Higuchi LM, Khalili H, Chan AT, et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol 2012; 107:1399–1406.
Butwicka A, Olen O, Larsson H, et al. Association of childhood-onset inflammatory bowel disease with risk of psychiatric disorders and suicide attempt. JAMA Pediatr 2019; 173:969–978.
Severs M, Mangen MJ, Fidder HH, et al. Clinical predictors of future nonadherence in inflammatory bowel disease. Inflamm Bowel Dis 2017; 23:1568–1576.
Baldwin KR, Kaplan JL. Medical management of pediatric inflammatory bowel disease. Semin Pediatr Surg 2017; 26:360–366.
DeFilippis EM, Sockolow R, Barfield E. Health care maintenance for the pediatric patient with inflammatory bowel disease. Pediatrics 2016; 138:e20151971doi:10.1542/peds.2015-1971.
doi: 10.1542/peds.2015-1971
Michel HK, Kim SC, Siripong N, et al. Gaps exist in the comprehensive care of children with inflammatory bowel diseases. J Pediatr 2020; 224:94–101.
Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17:1314–1321.
Cohen-Mekelburg S, Yu X, Costa D, et al. Variation in provider connectedness associates with outcomes of inflammatory bowel diseases in an analysis of data from a National Health System. Clin Gastroenterol Hepatol 2020; S1542-3565(20)31137-X. doi:10.1016/j.cgh.2020.08.028.
doi: 10.1016/j.cgh.2020.08.028
Cohen-Mekelburg S, Saini SD, Krein SL, et al. Association of continuity of care with outcomes in US veterans with inflammatory bowel disease. JAMA Netw Open 2020; 3:e2015899doi:10.1001/jamanetworkopen.2020.15899.
doi: 10.1001/jamanetworkopen.2020.15899

Auteurs

Christopher J Moran (CJ)

Division of Pediatric Gastroenterology, Hepatology, & Nutrition, MassGeneral Hospital for Children.
Department of Pediatrics, Harvard Medical School.

Emmanuel Aryee (E)

Division of General Academic Pediatrics, MassGeneral Hospital for Children, Boston, MA.

James M Perrin (JM)

Division of Pediatric Gastroenterology, Hepatology, & Nutrition, MassGeneral Hospital for Children.
Division of General Academic Pediatrics, MassGeneral Hospital for Children, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH